Nasometin (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasometin, is a corticosteroid presented as a nasal spray for nasal administration. It reduces inflammation in the nasal passages and is used to treat allergic rhinitis, seasonal and perennial allergic rhinitis, and nasal polyps in both adults and children.

GNH USA supplies Nasometin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Nasometin (mometasone furoate) is indicated for several nasal inflammatory conditions.

Allergic rhinitis: alleviates nasal congestion, itching and sneezing. Seasonal allergic rhinitis: reduces seasonal symptom severity. Perennial allergic rhinitis: controls year‑round nasal inflammation. Nasal polyps: shrinks polyp size and improves nasal airflow.

Nasal administration of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning - Headache - Epistaxis (nosebleed) - Altered taste - Throat irritation - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with extensive use - Fungal infection of the nasal passages - Increased intra‑ocular pressure

When using Nasometin, certain precautions should be observed to ensure safety and effectiveness.

- Use as prescribed: follow the healthcare professional’s instructions for frequency and duration. - Avoid prolonged continuous use: limit treatment to the period recommended to reduce risk of systemic effects. - Monitor for signs of infection: discontinue if persistent nasal infection develops. - Caution in glaucoma or cataract patients: topical steroids may raise intra‑ocular pressure. - Caution after nasal surgery or trauma: assess healing before initiating therapy. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate can interact with other medicines, affecting its safety profile.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise local steroid exposure.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): monitor for increased local irritation. - Nasal decongestant sprays: may exacerbate mucosal dryness. - Immunosuppressants: watch for heightened infection risk.